Ain Holdings Inc. · TSE:9627
Ain — FY4/24 Earnings Presentation
32 slides from Ain's earnings presentation, June 2024
Slide 1: FY4/24 IR Presentation
FY4/24 IR PRESENTATION June 2024
Slide 2: Results Overview
Results Overview © AIN HOLDINGS INC. All Rights Reserved. 1
Slide 3: Consolidated P/L
Consolidated P/L Net sales increased 11.5% YoY and 2.4% against the plan due to new store openings and growth at existing stores in both businesses. Ordinary profit increased 25.3% YoY and 10.5% against the plan. FY4/23 FY4/24 FY4/24 YoY YoY Vs （¥ million） results revised plan results change change(
Slide 4: Dispensing Pharmacy Business (Consolidated)
Dispensing Pharmacy Business (Consolidated) Net sales increased 11.2% YoY and 2.4% against the plan due to new store openings including M&A, growth at existing stores, and contribution of stores opened in the previous year. Segment profit increased 14.3% YoY and 4.5% against the plan. FY4/23 FY4/24
Slide 5: Cosmetic and Drug Store Business (Consolidated)
Cosmetic and Drug Store Business (Consolidated) Net sales up 21.1% YoY and 5.5% against the plan due to steady sales growth at both stores opened in the previous year and existing stores. Segment profit increased 155.0% YoY and 28.5% against the plan. FY4/23 FY4/24 FY4/24 YoY YoY Vs （¥ million） resu
Slide 6: Consolidated B/S
Consolidated B/S Net cash became ¥41,617 million and shareholders’ equity ratio became 54.3%. We are maintaining a sound financial structure. End-FY4/23 (¥ million) End-FY4/24 (¥ million) Assets Liabilities and Net Assets Assets Liabilities and Net Assets Current Current Current assets 98,305 liabil
Slide 7: Assets
Assets The balance of total assets increased ¥17,659 million from the end of the previous fiscal year because of increase in inventories and buildings and structures, net, etc., due to the new store openings. (¥ million) End-FY4/22 End-FY4/23 End-FY4/24 Change Cash and deposits 59,729 46,796 48,611
Slide 8: Liabilities and Net Assets
Liabilities and Net Assets Accounts payable increased ¥6,808 million due to new store openings and M&A. Short-term and long-term borrowings decreased ¥1,997 million. (¥ million) End-FY4/22 End-FY4/23 End-FY4/24 Change Accounts payable – trade 50,756 58,698 65,506 +6,808 Short-term borrowings 2,643 3
Slide 9: Consolidated C/F
Consolidated C/F Net cash provided by investing activities became ¥15,748 million due to M&A and new store openings and net cash provided by operating activities increased ¥23,023 million due to increase in profit before income taxes, etc. Because of them, cash and cash equivalents at end of the per
Slide 10: Business Value Analysis
Business Value Analysis FY4/22 FY4/23 FY4/24 Change Shareholders’ equity ratio (%) 56.0 54.6 54.3 (0.3) Market value equity ratio (%) 96.6 85.5 83.8 (1.7) PER (times) 28.99 21.46 18.39 (3.07) EPS (¥) 201.47 262.87 324.64 +61.77 PBR (times) 1.74 1.58 1.56 (0.02) BPS (¥) 3,385.51 3,599.47 3,866.55 +26
Slide 11: FY4/25 Plan (Consolidated)
FY4/25 Plan (Consolidated) The group forecasts net sales for the fiscal year ending April 30, 2025 increase 3.8% YoY due to new store openings of 80 stores for dispensing pharmacy business and 10 stores for cosmetic and drug store business. Ordinary profit will decrease 13.5% YoY due to increase in
Slide 12: Review
Review © AIN HOLDINGS INC. All Rights Reserved. 11
Slide 13: Consolidated (YoY)
Consolidated (YoY) Ordinary profit increased ¥4.3 billion YoY due to increase of net sales in dispensing pharmacy business and cosmetic and drug store business. Net sales Ordinary profit ¥358.7 billion ¥399.8 billion +¥41.1 billion ¥17.0 billion ¥21.3 billion +¥4.3 billion +11.5% +25.3% ■Dispensing
Slide 14: Consolidated (vs Revised Plan)
Consolidated (vs Revised Plan) Ordinary profit increased ¥2.0 billion against the revised plan due to increase in gross profit because the number of prescriptions increased in the dispensing pharmacy business, and decrease in SG&A expenses from the improvement of operational efficiency in the cosmet
Slide 15: Number of Pharmacies and Stores
Number of Pharmacies and Stores ■ Plan and Results FY4/24 FY4/25 Revised Plan Results Plan Dispensing Pharmacy 41 40 80 Organic 21 19 40 Opening M&A 20 21 40 Cosmetic and drug store 6 6 10 Total 47 46 90 Dispensing Pharmacy 10 18 16 Closure Cosmetic and drug store 2 3 2 Total 12 21 18 ■ Transition o
Slide 16: FY4/25 Plan
FY4/25 Plan © AIN HOLDINGS INC. All Rights Reserved. 15
Slide 17: Transition of dispensing fee revisions
Transition of dispensing fee revisions Although the company has been affected by the revision of dispensing fees and changes in social conditions, it has steadily increased earnings while realizing the role required of pharmacies and strengthening its management base. （¥ billion） （¥ billion） Respond
Slide 18: Strategy
Strategy © AIN HOLDINGS INC. All Rights Reserved. 17
Slide 19: Strategy
Strategy Expansion of top-line ■ Dispensing Pharmacy business strategy ■Organic store openings and utilization of M&A ■Further strengthening specialist skills of pharmacists and providing patients-centered pharmacy services ■ Cosmetic and drug store business strategy ■Organic store openings and util
Slide 20: Expansion of top-line
Expansion of top-line FY4/24 Results FY4/25 Plan 1,312 1,384 114 Dispensing Dispensing Pharmacies 1,231 Pharmacies 1,295 18 Cosmetics and Cosmetics and Drug stores 81 89 Drug stores 163 1 359 224 44 156 146 2 1 8 69 7 :Dispensing Pharmacies ：Cosmetic and drug stores © AIN HOLDINGS INC. All Rights Re
Slide 21: FY4/25 Plan (Dispensing Pharmacy Business)
FY4/25 Plan (Dispensing Pharmacy Business) The group forecasts net sales increase 3.3% YoY and segment profit decrease 9.2% YoY due to opening 80 new stores including M&A and closing 16 stores. FY4/23 FY4/24 FY4/25 YoY YoY （¥ million） results results plan change change (%) Net sales 321,577 357,571
Slide 22: Expansion of top-line: AINZ & TULPE stores opened in FY4/24
Expansion of top-line AINZ & TULPE 6 In FY4/24 opened 7 5 4 3 2 1 stores DUO KOBE COCONO SUSUKINO (Opened in Nov. 2023) （Opened in Nov. 2023) ecute UENO COCOLIA TAMA CENTER （Opened in Dec. 2023) (Opened in June 2023 ） © AIN HOLDINGS INC. All Rights Reserved. 21
Slide 23: Expansion of top-line: AINZ & TULPE openings planned FY4/25
Expansion of top-line AINZ & TULPE 10 店舗 In FY4/25 plan to open パース掲載 stores Tokyo A （Plan to open in Oct. 2024 ） Carrot St. SANCHA (Opened in June 2024) Tokyo B （Plan to open in Nov. 2024 ） EQUiA TAKENOTSUKA （Opened in May 2024） © AIN HOLDINGS INC. All Rights Reserved. 22
Slide 24: Expansion of top-line
Expansion of top-line Setting priority areas and Specialize in cosmetics and other opening flagship stores beauty products mainly in urban areas Number of prospective store openings Cosmetics and other beauty products 180 Hokkaido Prospective store openings 1 90% ■ Cosmetics and other beauty product
Slide 25: FY4/25 Plan (Cosmetic and Drug Store Business)
FY4/25 Plan (Cosmetic and Drug Store Business) The group forecasts net sales increase 6.8% YoY and segment profit increase 9.8% YoY due to opening 10 new stores and closing 2 stores. FY4/23 FY4/24 FY4/25 YoY YoY （¥ million） results results plan change change (%) Net sales 25,685 31,111 33,240 +2,129
Slide 26: Human capital
Human capital In April 2024, new 532 pharmacists has joined our group. We aim to hire about 600 new pharmacists in fiscal 2025. As of April 30,2024, the group has 6,478 pharmacists out of 15,114 employees. （people） 800 Pharmacists Medical support staff No. of newly hired 600 students 639 400 660 613
Slide 27: Digital transformation investment
Digital transformation investment Along with responding to deregulation of digital prescriptions and online eligibility checks, etc., the company utilize digital transformation to provide added value that only AIN Group can offer and to improve store operating efficiency. 経営基盤の強化 Reinforce the manag
Slide 28: Sustainability management
Sustainability management 1 We have conducted our corporate activities with common sense and ethics in order to realize our group statement of “the health and happiness of our customers" through our businesses contributing to people's health and beauty. Going forward, we will achieve sustainable cor
Slide 29: Sustainability management
Sustainability management 2 Within our Sustainability Committee, approximately 30 project teams are promoting cross-sectoral initiatives for each materiality. Stakeholder engagement Supply chain management We invited outside experts We held a briefing session and and hold a dialogue. We conducted a
Slide 30: FY4/25 Plan (Consolidated)
FY4/25 Plan (Consolidated) The group forecasts net sales for the fiscal year ending April 30, 2025 increase 3.8% YoY due to new store openings of 80 stores for dispensing pharmacy business and 10 stores for cosmetic and drug store business. Ordinary profit will decrease 13.5% YoY due to increase in
Slide 31: AIN Holdings Inc. Corporate Planning Division
Inquiries related to this presentation should be addressed to AIN HOLDINGS INC. Corporate Planning Division TEL(81)11-814-0010 FAX(81)11-814-5550 https://www.ainj.co.jp/corporate/ This document may not be reproduced or distributed to any third party without prior approval of AIN HOLDINGS INC. This d
Slide 32: AIN GROUP
AIN GROUP